These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34272700)

  • 1. Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).
    Zhou J; Argikar UA; Miners JO
    Methods Mol Biol; 2021; 2342():301-338. PubMed ID: 34272700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme kinetics of uridine diphosphate glucuronosyltransferases (UGTs).
    Zhou J; Miners JO
    Methods Mol Biol; 2014; 1113():203-28. PubMed ID: 24523115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential.
    Miners JO; Mackenzie PI; Knights KM
    Drug Metab Rev; 2010 Feb; 42(1):196-208. PubMed ID: 19795925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UDP-glucuronic acid binds first and the aglycone substrate binds second to form a ternary complex in UGT1A9-catalyzed reactions, in both the presence and absence of bovine serum albumin.
    Manevski N; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2012 Nov; 40(11):2192-203. PubMed ID: 22912433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of UDP-sugars, UDP and Mg
    Walia G; Smith AD; Riches Z; Collier AC; Coughtrie MWH
    Xenobiotica; 2018 Sep; 48(9):882-890. PubMed ID: 28868965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: pitfalls and promises.
    Miners JO; Knights KM; Houston JB; Mackenzie PI
    Biochem Pharmacol; 2006 May; 71(11):1531-9. PubMed ID: 16455060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping.
    Miners JO; Rowland A; Novak JJ; Lapham K; Goosen TC
    Pharmacol Ther; 2021 Feb; 218():107689. PubMed ID: 32980440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.
    Nair PC; Chau N; McKinnon RA; Miners JO
    Mol Pharmacol; 2020 Dec; 98(6):710-718. PubMed ID: 33008919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carrier-mediated transport of uridine diphosphoglucuronic acid across the endoplasmic reticulum membrane is a prerequisite for UDP-glucuronosyltransferase activity in rat liver.
    Bossuyt X; Blanckaert N
    Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):645-8. PubMed ID: 9169596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complexities of glucuronidation affecting in vitro in vivo extrapolation.
    Lin JH; Wong BK
    Curr Drug Metab; 2002 Dec; 3(6):623-46. PubMed ID: 12369890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
    Chau N; Elliot DJ; Lewis BC; Burns K; Johnston MR; Mackenzie PI; Miners JO
    J Pharmacol Exp Ther; 2014 Apr; 349(1):126-37. PubMed ID: 24459244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The enzymatic mechanism of glucuronidation catalyzed by two purified rat liver steroid UDP-glucuronosyltransferases.
    Falany CN; Green MD; Tephly TR
    J Biol Chem; 1987 Jan; 262(3):1218-22. PubMed ID: 3100528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine serum albumin decreases Km values of human UDP-glucuronosyltransferases 1A9 and 2B7 and increases Vmax values of UGT1A9.
    Manevski N; Moreolo PS; Yli-Kauhaluoma J; Finel M
    Drug Metab Dispos; 2011 Nov; 39(11):2117-29. PubMed ID: 21856742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of daphnetin.
    Liang SC; Ge GB; Liu HX; Zhang YY; Wang LM; Zhang JW; Yin L; Li W; Fang ZZ; Wu JJ; Li GH; Yang L
    Drug Metab Dispos; 2010 Jun; 38(6):973-80. PubMed ID: 20176691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A membrane transporter mediates access of uridine 5'-diphosphoglucuronic acid from the cytosol into the endoplasmic reticulum of rat hepatocytes: implications for glucuronidation reactions.
    Hauser SC; Ziurys JC; Gollan JL
    Biochim Biophys Acta; 1988 Nov; 967(2):149-57. PubMed ID: 3142526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The first aspartic acid of the DQxD motif for human UDP-glucuronosyltransferase 1A10 interacts with UDP-glucuronic acid during catalysis.
    Xiong Y; Patana AS; Miley MJ; Zielinska AK; Bratton SM; Miller GP; Goldman A; Finel M; Redinbo MR; Radominska-Pandya A
    Drug Metab Dispos; 2008 Mar; 36(3):517-22. PubMed ID: 18048489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoaffinity labeling studies of the human recombinant UDP-glucuronosyltransferase, UGT1*6, with 5-azido-UDP-glucuronic acid.
    Battaglia E; Nowell S; Drake RR; Magdalou J; Fournel-Gigleux S; Senay C; Radominska A
    Drug Metab Dispos; 1997 Apr; 25(4):406-11. PubMed ID: 9107538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of Experimental Conditions of Automated Glucuronidation Assays in Human Liver Microsomes Using a Cocktail Approach and Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Badée J; Qiu N; Parrott N; Collier AC; Schmidt S; Fowler S
    Drug Metab Dispos; 2019 Feb; 47(2):124-134. PubMed ID: 30478159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.
    Loureiro AI; Fernandes-Lopes C; Bonifácio MJ; Wright LC; Soares-da-Silva P
    Drug Metab Dispos; 2011 Sep; 39(9):1486-94. PubMed ID: 21673130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.